Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerColon and RectalMelanomaGenitourinary Cancer
High BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerOncologyGenitourinary Cancer
Atezolizumab doubles survival of NSCLC patients with poor performance statusSeptember 19, 2022Lung CancerOncology
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerLung CancerMelanomaRare Diseases
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerOncologyGenitourinary CancerLung CancerMelanoma
Opioids after lung cancer surgery may up all-cause mortality riskSeptember 15, 2022Lung CancerOncology
‘Smoking gun–level’ evidence found linking air pollution with lung cancerSeptember 14, 2022Lung CancerOncologyMelanoma
Reporting Coronary Artery Calcium on Low-Dose Computed Tomography Impacts Statin Management in a Lung Cancer Screening PopulationSeptember 12, 2022OncologyLung Cancer
Evaluating Progression Free Survival Among Veteran Population With Stage IV Non-Small Cell Immunotherapy vs Chemo- ImmunotherapySeptember 2, 2022Lung CancerOncology
MYO1E DNA Methylation in U.S. Military Veterans With Adenocarcinoma of the Lung Is Associated With Increased Mortality RiskAugust 30, 2022Lung CancerOncology
Molecular Profiling of Lung Malignancies in Veterans: What We Have Learned About the Impact of Agent Orange ExposureAugust 30, 2022Lung CancerOncology
